Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

CollPlant Biotechnologies (CLGN) Equity Ratio (2018 - 2024)

Historic Equity Ratio for CollPlant Biotechnologies (CLGN) over the last 7 years, with Q4 2024 value amounting to 0.72.

  • CollPlant Biotechnologies' Equity Ratio fell 1334.01% to 0.72 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.72, marking a year-over-year decrease of 1334.01%. This contributed to the annual value of 0.72 for FY2024, which is 1334.01% down from last year.
  • CollPlant Biotechnologies' Equity Ratio amounted to 0.72 in Q4 2024, which was down 1334.01% from 0.83 recorded in Q4 2023.
  • CollPlant Biotechnologies' Equity Ratio's 5-year high stood at 0.88 during Q4 2021, with a 5-year trough of 0.41 in Q4 2020.
  • In the last 5 years, CollPlant Biotechnologies' Equity Ratio had a median value of 0.78 in 2023 and averaged 0.7.
  • Its Equity Ratio has fluctuated over the past 5 years, first surged by 11329.83% in 2021, then plummeted by 1334.01% in 2024.
  • CollPlant Biotechnologies' Equity Ratio (Quarter) stood at 0.41 in 2020, then skyrocketed by 113.3% to 0.88 in 2021, then fell by 2.97% to 0.85 in 2022, then dropped by 2.84% to 0.83 in 2023, then fell by 13.34% to 0.72 in 2024.
  • Its Equity Ratio was 0.72 in Q4 2024, compared to 0.83 in Q4 2023 and 0.85 in Q4 2022.